Sodium ferric gluconate complex

Sodium ferric gluconate complex
Clinical data
Trade names	Ferrlecit
AHFS/Drugs.com	FDA Professional Drug Information
Pregnancy category	US: B (No risk in non-human studies)
Routes of administration	Intravenous
ATC code	B03AC (WHO)
Legal status
Legal status	US: ℞-only
Identifiers

Sodium ferric gluconate complex (brand name Ferrlecit by Sanofi), is an intravenously administered iron product indicated in the treatment of iron deficiency anemia. It is frequently used in patients undergoing hemodialysis, those undergoing erythropoietin therapy, and/or patients who have chronic kidney disease.

References

Other hematological agents

Antianemic
preparations
(B03)

Erythropoietins	Darbepoetin alfa Methoxy polyethylene glycol-epoetin beta Peginesatide

Iron supplements	Ferrous ascorbate Ferrous aspartate Ferrous carbonate Ferrous chloride Ferrous fumarate Ferrous gluconate Ferrous glycine sulfate Ferrous iodine Ferrous succinate Ferrous sulfate Ferrous tartrate Iron sucrose Sodium ferric gluconate complex

Blood substitutes and
perfusion solutions (B05)

Dextran
Gelatin agents
Hemoglobin crosfumaril
Hemoglobin raffimer
Hydroxyethyl starch
Icodextrin
Mannitol
Serum albumin
Sorbitol

Enzymes (B06AA)

Drugs used i hereditary
angioedema (B06AC)

This article is issued from Wikipedia - version of the 1/2/2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.